These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 10413847

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Four basic characteristics of the gastrin-cholecystokinin system.
    Rehfeld JF.
    Am J Physiol; 1981 Apr; 240(4):G255-66. PubMed ID: 7013499
    [Abstract] [Full Text] [Related]

  • 43. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF.
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [Abstract] [Full Text] [Related]

  • 44. Characterization of the cholecystokinin and gastrin genes from the bullfrog, Rana catesbeiana: evolutionary conservation of primary and secondary sites of gene expression.
    Rourke IJ, Rehfeld JF, Møller M, Johnsen AH.
    Endocrinology; 1997 Apr; 138(4):1719-27. PubMed ID: 9075736
    [Abstract] [Full Text] [Related]

  • 45. Pancreatic secretory response to feeding in the calf: CCK-A receptors, but not CCK-B/gastrin receptors are involved.
    Le Dréan G, Le Huërou-Luron I, Gestin M, Romé V, Bernard C, Chayvialle JA, Fourmy D, Guilloteau P.
    Can J Physiol Pharmacol; 2000 Oct; 78(10):813-9. PubMed ID: 11077982
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R.
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Relaxin-3, INSL5, and their receptors.
    Liu C, Lovenberg TW.
    Results Probl Cell Differ; 2008 Sep; 46():213-37. PubMed ID: 18236022
    [Abstract] [Full Text] [Related]

  • 52. Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.
    Morton MF, Pyati J, Dai H, Li L, Moreno V, Shankley NP.
    Br J Pharmacol; 2005 Jun; 145(3):374-84. PubMed ID: 15765098
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Vasodilatory effects of cholecystokinin: new role for an old peptide?
    Ruiz-Gayo M, González MC, Fernández-Alfonso S.
    Regul Pept; 2006 Dec 10; 137(3):179-84. PubMed ID: 16889840
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Gastrins, cholecystokinins and gastrointestinal cancer.
    Aly A, Shulkes A, Baldwin GS.
    Biochim Biophys Acta; 2004 Jul 06; 1704(1):1-10. PubMed ID: 15238241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.